Trials / Completed
CompletedNCT04683562
Netrin-1 and Placenta Accreta
The Implication of Placental Netrin-1 Receptor DCC in the Pathophysiology of Placenta Accreta
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Netrin-1 is a secreted protein, which was first identified as a neuronal guidance factor. It is expressed in a multitude of tissues as pancreas, lung, breast, and placenta. Netrin-1 is a multifunctional protein, involved in cell polarity, adhesion, angiogenesis, apoptosis, migration, morphogenesis, and differentiation of various cell types. Most of netrin-1 activity occur through signaling pathways induced by its two main receptors, DCC (deleted in colorectal cancer) and UNC5H (uncoordinated-5 homolog). Its receptors have been linked to the processes of apoptosis and angiogenesis. In absence of netrin-1, DCC and UNC5H receptors lead to apoptosis. In contrary, in presence of netrin-1, receptors transduce molecular cascades leading to proliferation, differentiation and migration of the cells. Netrin-1 has been involved in the pathogenesis of multiple diseases, as diabetes, cardiovascular diseases, and cancer. Serum Netrin-1 levels were high in preeclamptic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pregnant women at 28-32 weeks | Pregnant women at gestational age 28-32 weeks |
| OTHER | at delivery | women delivered at term |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-01
- First posted
- 2020-12-24
- Last updated
- 2022-08-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04683562. Inclusion in this directory is not an endorsement.